| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.22T | — |
| Operating expense | — | — |
| Net income | 113.20B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TKPHF returned +20.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +18.2% |
| 1 year | +20.3% |
| 5 years | +22.7% |
| 10 years | +14.8% |
| All-time high | $58.92 (Jan 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TKPHF would be worth today ›Yes. Takeda Pharmaceutical Company Limited paid 1 dividend over the past 12 months. The most recent was $0.67 per share on Sep 29, 2025. The dividend yield is 3.56%.
Takeda Pharmaceutical Company Limited is part of the Healthcare sector.
Takeda Pharmaceutical Company Limited has a market cap of 54.29B USD, based on the latest quote.
Takeda Pharmaceutical Company Limited is scheduled to report earnings on Oct 29, 2026.
